Rchr
J-GLOBAL ID：200901077609938286   Update date: Jun. 28, 2024

Masaya Tanno

タンノ マサヤ | Masaya Tanno
Affiliation and department：
Sapporo Medical University

About Sapporo Medical University


Job title： Professor
Research field  (1)： Other
Research theme for competitive and other funds  (15)：
  • 2022 - 2025 ネクロプトーシス実行因子MLKLを標的とした心不全治療の開発
  • 2021 - 2024 AMPデアミナーゼ活性制御機構の解明と糖尿病性心筋症治療への応用
  • 2021 - 2024 Intracellular signal transduction regulating necroptosis of cardiomyocytes
  • 2021 - 2024 Role of non-classical renin-angiotensin system in contrast induced nephropathy
  • 2019 - 2022 Necroptosis-tartgeted therapy for heart failure
Show all
Papers (121)：
  • Yuki Toda, Sang-Bing Ong, Toshiyuki Yano, Atsushi Kuno, Hidemichi Kouzu, Tatsuya Sato, Wataru Ohwada, Yuki Tatekoshi, Toshifumi Ogawa, Masaki Shimizu, et al. Downregulation of Mitochondrial Fusion Protein Expression Affords Protection from Canonical Necroptosis in H9c2 Cardiomyoblasts. International Journal of Molecular Sciences. 2024. 25. 5. 2905-2905
  • Tetsuji Miura, Hidemichi Kouzu, Masaya Tanno, Yuki Tatekoshi, Atsushi Kuno. Role of AMP deaminase in diabetic cardiomyopathy. Molecular and Cellular Biochemistry. 2024
  • Takahiro Noto, Arata Osanami, Nobutaka Nagano, Nobuaki Kokubu, Hidemichi Kouzu, Masaya Tanno. Early Commencement and Long-Term Continuation of Tolvaptan Treatment Attenuate Functional Impairment of Renal Vasopressin V2 Receptors and Improve Clinical Outcomes in Patients with Heart Failure. International Heart Journal. 2023. 64. 1. 36-43
  • 小川 俊史, 神津 英至, 長南 新太, 清水 将輝, 戸田 悠貴, 大和田 渉, 佐藤 達也, 矢野 俊之, 久野 篤史, 丹野 雅也, et al. Downregulation of BCKDH Activity and Uncoupling from AMP Deaminase Underlie Substrate Inflexibility in Type 2 Diabetic Hearts(タイトル和訳中). 日本循環器学会学術集会抄録集. 2023. 87回. OJ03-2
  • Arata Osanami, Tatsuya Sato, Yuki Toda, Masaki Shimizu, Atsushi Kuno, Hidemichi Kouzu, Toshiyuki Yano, Wataru Ohwada, Toshifumi Ogawa, Tetsuji Miura, et al. Adenosine monophosphate deaminase in the endoplasmic reticulum-mitochondria interface promotes mitochondrial Ca2+ overload in type 2 diabetes rat hearts. Journal of diabetes investigation. 2023
ｍore...
MISC (179)：
  • Arata Osanami, Masaya Tanno, Atsushi Kuno, Hidemichi Kouzu, Toshiyuki Yano, Tatsuya Sato, Tetsuji Miura, Toshifumi Ogawa. AMP Deaminase in Mitochondria-Associated ER Membranes Contributes to Reduction of the Threshold for Mitochondrial Permeability Transition in Type 2 Diabetic Hearts. CIRCULATION. 2021. 144
  • 丹野雅也, 長南新太, 小川俊史, 神津英至. Emerging roles of AMP deaminase in the pathophysiology of diabetic cardiomyopathy. Bio Clinica. 2021. 36. 8. 762-767
  • Ogawa Toshifumi, Kouzu Hidemichi, Osanami Arata, Tatekoshi Yuki, Mizuno Masashi, Kuno Atsushi, Sugawara Hirohito, Fujita Yugo, Ino Shoya, Ohwada Wataru, et al. AMPデアミナーゼによる心臓分岐鎖アミノ酸代謝の新規制御 糖尿病性心筋症の治療標的としての期待(Novel Regulation of Cardiac Branched-chain Amino Acid Metabolism through AMP Deaminase: A Possible Therapeutic Target for Diabetic Cardiomyopathy). 日本循環器学会学術集会抄録集. 2021. 85回. OE081-3
  • 高橋 遼, 國分 宣明, 小山 雅之, 岸上 直広, 中田 潤, 西川 諒, 村上 直人, 永野 伸卓, 丹野 雅也, 大西 浩文, et al. Relationship between Risk Factor Management and Lesion Distribution in Coronary Artery Stenosis: A Cross-sectional Analysis of BOREAS-CAG Registry Data(和訳中). 日本循環器学会学術集会抄録集. 2021. 85回. OJ06-3
  • 丹野雅也, 神津英至, 三浦哲嗣. 糖尿病性心筋症の病態・治療の現状とこれから. 糖尿病学の進歩. 2021. 55th
ｍore...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM